Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments

Details for Australian Patent Application No. 2002344151 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Peukert, Stefan; Neises, Berd; Herling, Andreas; Klabunde, Thomas; Von Roedern, Erich; Bauer, Armin; Wendt, Karl Ulrich; Burger, Hans-Joerg; Defossa, Elisabeth; Enhsen, Alfons

Agent Watermark

Pub. Number AU-B-2002344151

PCT Number PCT/EP02/05205

PCT Pub. Number WO2002/096864

Priority 10125567.5 25.05.01 DE; 102 07 369.4 21.02.02 DE

Filing date 11 May 2002

Wipo publication date 9 December 2002

Acceptance publication date 18 January 2007

International Classifications

C07D 295/12 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/17 (2006.01) - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

A61K 31/197 (2006.01)

A61K 31/198 (2006.01)

A61K 31/221 (2006.01)

A61K 31/223 (2006.01)

A61K 31/245 (2006.01)

A61K 31/27 (2006.01)

A61K 31/277 (2006.01)

A61K 31/357 (2006.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61K 31/36 (2006.01)

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/404 (2006.01)

A61K 31/4045 (2006.01)

A61K 31/433 (2006.01) - Thiadiazoles

A61K 31/4406 (2006.01) - only substituted in position 3, e.g. zimeldine

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/4545 (2006.01)

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 10125567.5 25.05.01 DE; 102 07 369.4 21.02.02 DE

8 May 2003 Application Open to Public Inspection

  Published as AU-B-2002344151

22 December 2005 Assignment before Grant

  Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH

18 January 2007 Application Accepted

  Published as AU-B-2002344151

17 May 2007 Standard Patent Sealed

4 December 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002344152-POLYMER COMPOSITIONS AND USES THEREOF

2002344150-ATTACHMENT FOR AN OPENING, GRADING OR COMBING DEVICE ON TEXTILE MACHINERY